Marshall Wace »

Cidara Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 235k 95.76
2025-06-30 $12M 243k 48.71

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms-a Common Stock (META)
Circle Internet Common Stock (CRCL)
Boston Scientifc Common Stock (BSX)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Adv Micro Device Common Stock (AMD)
Market Vectors S Equity Option Call Option (SMH)
Walmart Common Stock (WMT)
Johnson&johnson Common Stock (JNJ)
Cencora Common Stock (COR)

View all positions for Marshall Wace

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics